- Home
- DTIL vs BAFN Comparison
DTIL vs BAFN Comparison
Compare DTIL & BAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTIL
- BAFN
- Stock Information
- Founded
- DTIL 2006
- BAFN 1999
- Country
- DTIL United States
- BAFN United States
- Employees
- DTIL N/A
- BAFN N/A
- Industry
- DTIL Biotechnology: Pharmaceutical Preparations
- BAFN Savings Institutions
- Sector
- DTIL Health Care
- BAFN Finance
- Exchange
- DTIL Nasdaq
- BAFN Nasdaq
- Market Cap
- DTIL 55.3M
- BAFN 63.2M
- IPO Year
- DTIL 2019
- BAFN N/A
- Fundamental
- Price
- DTIL $5.44
- BAFN $10.38
- Analyst Decision
- DTIL Strong Buy
- BAFN
- Analyst Count
- DTIL 2
- BAFN 0
- Target Price
- DTIL $47.00
- BAFN N/A
- AVG Volume (30 Days)
- DTIL 93.0K
- BAFN 8.3K
- Earning Date
- DTIL 11-03-2025
- BAFN 10-30-2025
- Dividend Yield
- DTIL N/A
- BAFN 3.08%
- EPS Growth
- DTIL N/A
- BAFN 100.65
- EPS
- DTIL N/A
- BAFN 1.89
- Revenue
- DTIL $1,261,000.00
- BAFN $78,211,000.00
- Revenue This Year
- DTIL N/A
- BAFN N/A
- Revenue Next Year
- DTIL $135.19
- BAFN N/A
- P/E Ratio
- DTIL N/A
- BAFN $5.50
- Revenue Growth
- DTIL N/A
- BAFN 0.67
- 52 Week Low
- DTIL $3.61
- BAFN $6.40
- 52 Week High
- DTIL $9.81
- BAFN $19.75
- Technical
- Relative Strength Index (RSI)
- DTIL 62.03
- BAFN 61.48
- Support Level
- DTIL $5.26
- BAFN $9.05
- Resistance Level
- DTIL $5.56
- BAFN $11.34
- Average True Range (ATR)
- DTIL 0.22
- BAFN 0.49
- MACD
- DTIL 0.06
- BAFN 0.32
- Stochastic Oscillator
- DTIL 88.68
- BAFN 71.36
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
About BAFN BayFirst Financial Corp.
BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.